Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
58.25
-0.76 (-1.29%)
May 13, 2025, 4:00 PM - Market closed
Globus Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 185.56 | 102.98 | 122.87 | 190.17 | 149.19 | 102.29 | Upgrade
|
| Depreciation & Amortization | 264.77 | 254.02 | 144.73 | 68.25 | 69.87 | 62.87 | Upgrade
|
| Loss (Gain) From Sale of Assets | 8.13 | 5.55 | 1.54 | 0.3 | 0.46 | 0.81 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 12.61 | - | 0.15 | 34.31 | 24.42 | Upgrade
|
| Loss (Gain) From Sale of Investments | -1.08 | -0.64 | 0.79 | 5.39 | 2.78 | 0.59 | Upgrade
|
| Stock-Based Compensation | 50.14 | 54.19 | 52.74 | 32.81 | 30.59 | 27.07 | Upgrade
|
| Provision & Write-off of Bad Debts | 17.22 | 16.99 | 3.66 | -0 | 1.2 | 2.96 | Upgrade
|
| Other Operating Activities | 166.05 | 172.48 | 33.76 | -13.34 | 5.13 | 15.38 | Upgrade
|
| Change in Accounts Receivable | -19.07 | -78.06 | -49.91 | -50.84 | -25.9 | 10.7 | Upgrade
|
| Change in Inventory | -28.46 | -29.86 | -70.33 | -61.75 | -11.97 | -50.11 | Upgrade
|
| Change in Accounts Payable | 22.52 | 17.66 | -14.22 | 14.42 | 3.68 | -6.35 | Upgrade
|
| Change in Income Taxes | -34.29 | -13.38 | -0.41 | -2.89 | 5.21 | 1.66 | Upgrade
|
| Change in Other Net Operating Assets | 14.06 | 6.08 | 18.28 | -4.21 | 11.72 | 6.52 | Upgrade
|
| Operating Cash Flow | 645.55 | 520.64 | 243.5 | 178.47 | 276.27 | 198.79 | Upgrade
|
| Operating Cash Flow Growth | 166.13% | 113.81% | 36.44% | -35.40% | 38.98% | 15.59% | Upgrade
|
| Capital Expenditures | -122.96 | -115.43 | -78.27 | -74.05 | -56.9 | -63.66 | Upgrade
|
| Cash Acquisitions | -4.99 | -17.64 | -296.03 | -31.44 | -34.49 | -33.48 | Upgrade
|
| Investment in Securities | 134.87 | -42.99 | 677.27 | -4.88 | -284.55 | -20.18 | Upgrade
|
| Investing Cash Flow | 1.92 | -176.05 | 302.97 | -110.36 | -375.94 | -117.32 | Upgrade
|
| Issuance of Common Stock | 118.25 | 110.44 | 12.4 | 41.72 | 63.5 | 72.32 | Upgrade
|
| Repurchase of Common Stock | -196.6 | -92.52 | -236.18 | -144.49 | - | -104.67 | Upgrade
|
| Other Financing Activities | -19.03 | -45.62 | -8.04 | -7.19 | -9.35 | -6.32 | Upgrade
|
| Financing Cash Flow | -547.37 | -27.7 | -231.82 | -109.96 | 54.15 | -38.66 | Upgrade
|
| Foreign Exchange Rate Adjustments | 7.11 | 0.26 | 2.18 | -0.75 | -0.81 | 0.87 | Upgrade
|
| Net Cash Flow | 107.2 | 317.15 | 316.83 | -42.6 | -46.33 | 43.67 | Upgrade
|
| Free Cash Flow | 522.59 | 405.21 | 165.23 | 104.42 | 219.38 | 135.14 | Upgrade
|
| Free Cash Flow Growth | 244.44% | 145.25% | 58.23% | -52.40% | 62.34% | 33.50% | Upgrade
|
| Free Cash Flow Margin | 20.81% | 16.08% | 10.53% | 10.21% | 22.90% | 17.13% | Upgrade
|
| Free Cash Flow Per Share | 3.76 | 2.94 | 1.44 | 1.02 | 2.12 | 1.34 | Upgrade
|
| Cash Income Tax Paid | 163.74 | 158.51 | 100.59 | 77.82 | 45.03 | 25.44 | Upgrade
|
| Levered Free Cash Flow | 639.43 | 598.37 | -346.92 | 75.52 | 160.53 | 88.28 | Upgrade
|
| Unlevered Free Cash Flow | 640.86 | 600.98 | -346.92 | 75.52 | 160.53 | 88.28 | Upgrade
|
| Change in Net Working Capital | -168.98 | -132.56 | 637.06 | 99.71 | 4.81 | 10.18 | Upgrade
|
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.